Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
African American Study of Kidney Disease and Hypertension
NCT04364139Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Feb 1995
- Primary completion
- Sep 2001
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of ramipril, amlodipine and metoprolol in hypertensive nephrosclerosis (HN) and chronic kidney disease (CKD) (6 arms), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoint: Rate of change in Glomerular Filtration Rate at 3 years. Started Feb 1995; status: completed.
02
Drugs
ramiprilamlodipinemetoprolol
03
Conditions
hypertensive nephrosclerosis (HN)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT04364139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04364139.